The development of immune checkpoint inhibitors (ICI) has revolutionized cancer treatment. ICI enhance antitumor immunity by inhibiting the negative regulatory components of the T cell-mediated immune response against tumor cells. ICI are associated with less ... ...

请注册登录后继续浏览